New Risk • Apr 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Market cap is less than US$100m (NZ$45.1m market cap, or US$26.4m). Reported Earnings • Nov 28
First half 2026 earnings released: US$0.001 loss per share (vs US$0.004 loss in 1H 2025) First half 2026 results: US$0.001 loss per share (improved from US$0.004 loss in 1H 2025). Revenue: US$14.2m (up 11% from 1H 2025). Net loss: US$600.0k (loss narrowed 71% from 1H 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. New Risk • Sep 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of New Zealander stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Earnings have declined by 67% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (NZ$64.0m market cap, or US$37.8m). Recent Insider Transactions • Aug 30
President & CEO recently bought NZ$82k worth of stock On the 28th of August, Justin Birch bought around 750k shares on-market at roughly NZ$0.11 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Justin's only on-market trade for the last 12 months. Announcement • Jul 11
ArborGen Holdings Limited, Annual General Meeting, Sep 10, 2025 ArborGen Holdings Limited, Annual General Meeting, Sep 10, 2025. Location: auckland New Zealand Reported Earnings • May 31
Full year 2025 earnings released: US$0.041 loss per share (vs US$0 in FY 2024) Full year 2025 results: US$0.041 loss per share (further deteriorated from US$0 in FY 2024). Revenue: US$63.2m (down 6.6% from FY 2024). Net loss: US$21.5m (loss widened US$21.3m from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. New Risk • May 31
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$5.1m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$5.1m free cash flow). Earnings have declined by 67% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NZ$76.6m market cap, or US$45.8m). Announcement • Nov 29
ArborGen Holdings Limited Revises Group Earnings Guidance for the Full Year 2025 ArborGen Holdings Limited revised group earnings guidance for the full year 2025. The company's overall goal remains to drive sales of its advanced genetics seedlings in its target markets in the US South and Brazil, both of which offer strong growth and commercial potential. Growth momentum and higher volumes are expected in Brazil in second half of 2025 following the softer first half year. Headwinds in the US South are expected to continue to impact across the industry, resulting in lower demand and offsetting the growth in Brazil. Given this, the company expects full year 2025 sales volumes to be down on last year with a corresponding impact on earnings. Reported Earnings • Nov 29
First half 2025 earnings released: US$0.004 loss per share (vs US$0 in 1H 2024) First half 2025 results: US$0.004 loss per share (further deteriorated from US$0 in 1H 2024). Revenue: US$12.8m (down 3.0% from 1H 2024). Net loss: US$2.10m (loss widened US$2.00m from 1H 2024). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Announcement • Jul 22
ArborGen Holdings Limited, Annual General Meeting, Aug 26, 2024 ArborGen Holdings Limited, Annual General Meeting, Aug 26, 2024. Location: hunterville room, ellerslie event centre, 100 ascot avenue, remuera, and, auckland New Zealand Reported Earnings • Jun 25
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: EPS: US$0 (improved from US$0.005 loss in FY 2023). Revenue: US$67.7m (up 21% from FY 2023). Net loss: US$200.0k (loss narrowed 92% from FY 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Reported Earnings • Jun 04
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: EPS: US$0 (improved from US$0.005 loss in FY 2023). Revenue: US$67.7m (up 21% from FY 2023). Net loss: US$200.0k (loss narrowed 92% from FY 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) also surpassed analyst estimates. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Reported Earnings • Dec 01
First half 2024 earnings released: EPS: US$0 (vs US$0.003 loss in 1H 2023) First half 2024 results: EPS: US$0 (improved from US$0.003 loss in 1H 2023). Revenue: US$13.2m (up 78% from 1H 2023). Net loss: US$100.0k (loss narrowed 94% from 1H 2023). Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Global Forestry industry. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Announcement • Aug 01
ArborGen Holdings Limited Announces Executive Changes ArborGen Holdings Limited announced Adriano E. Amaral de Almeida will assume the role of General Manager of its Brazil operations. Adriano succeeds Gabriela Monnerat, who will continue in a consulting capacity to facilitate a seamless transition. Amaral de Almeida comes to the company with more than 20 years in tree improvement science and breeding. More recently, he was the head of Acacia and Eucalyptus tree improvement at APRIL Indonesia where he was responsible for the tree breeding program, including the biomolecular lab, genomic projects, wood properties lab, Acacia and Eucalyptus seed production, and research and development project management. Amaral de Almeida has a bachelor's degree in forestry engineering from Viçosa Federal University, a master's degree in forest science from Viçosa Federal University, and a master's of innovation management from Campinas University. Announcement • Jun 14
ArborGen Holdings Limited, Annual General Meeting, Sep 20, 2023 ArborGen Holdings Limited, Annual General Meeting, Sep 20, 2023. Location: the Ellerslie Event Centre in Auckland in the Remuera Room Auckland City New Zealand Reported Earnings • Jun 01
Full year 2023 earnings released: US$0.005 loss per share (vs US$0.003 profit in FY 2022) Full year 2023 results: US$0.005 loss per share (down from US$0.003 profit in FY 2022). Revenue: US$56.1m (up 18% from FY 2022). Net loss: US$2.50m (down 247% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Reported Earnings • Dec 01
First half 2023 earnings released: US$0.003 loss per share (vs US$0.001 loss in 1H 2022) First half 2023 results: US$0.003 loss per share (further deteriorated from US$0.001 loss in 1H 2022). Revenue: US$7.40m (up 61% from 1H 2022). Net loss: US$1.60m (loss widened 220% from 1H 2022). Revenue is forecast to grow 26% p.a. on average during the next 2 years, compared to a 1.6% growth forecast for the Global Forestry industry. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Sep 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 03
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: US$0.003 (vs US$0.003 in FY 2021). Revenue: US$47.6m (up 11% from FY 2021). Net income: US$1.70m (up 13% from FY 2021). Profit margin: 3.6% (in line with FY 2021). Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the next year, revenue is forecast to grow 46%, compared to a 18% growth forecast for the industry in New Zealand. Over the last 3 years on average, earnings per share has increased by 97% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Announcement • Jun 30
ArborGen Holdings Limited Announces the Resignation of Ranjan Tandon from Board ArborGen Holdings Limited announced that Ranjan Tandon has notified the Company that he will resign from the ArborGen Board effective 30 June 2022. Mr. Tandon has resigned from the ArborGen Board in order to devote more time to his other commitments, in particular his involvement in philanthropic and other business activities. The ArborGen Board and management would like to recognise the significant contribution that Mr. Tandon has made to ArborGen during his Board tenure and thank Mr. Tandon. Announcement • Jun 23
ArborGen Holdings Limited, Annual General Meeting, Aug 24, 2022 ArborGen Holdings Limited, Annual General Meeting, Aug 24, 2022, at 10:00 NZST - New Zealand Standard. Location: Ellerslie Event Centre in Auckland Remuera Room Auckland City New Zealand Reported Earnings • May 31
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: US$0.003 (down from US$0.006 in FY 2021). Revenue: US$47.6m (down 9.7% from FY 2021). Net income: US$1.70m (down 47% from FY 2021). Profit margin: 3.6% (down from 6.1% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 25%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the next year, revenue is forecast to grow 45%, compared to a 11% growth forecast for the industry in New Zealand. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 25
First half 2022 earnings: EPS and revenues miss analyst expectations First half 2022 results: US$0.001 loss per share (down from US$0.005 profit in 1H 2021). Revenue: US$4.60m (up 59% from 1H 2021). Net loss: US$500.0k (down 121% from profit in 1H 2021). Revenue missed analyst estimates by 5.0%. Earnings per share (EPS) were also behind analyst expectations. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 21%, compared to a 9.7% growth forecast for the industry in New Zealand. Board Change • Nov 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Independent & Non-executive Director T. H. Adams was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jul 01
An unknown buyer made an non-binding and an indicative proposal to acquire ArborGen Holdings Limited (NZSE:ARB). An unknown buyer made an non-binding and an indicative proposal to acquire ArborGen Holdings Limited (NZSE:ARB) on June 30, 2021. In light of this, the Board of ArborGen has decided to commence a strategic review. Reported Earnings • May 29
Full year 2021 earnings released: EPS US$0.006 (vs US$0.005 loss in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: US$52.7m (down 7.4% from FY 2020). Net income: US$3.20m (up US$5.90m from FY 2020). Profit margin: 6.1% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 28
First half 2021 earnings released: EPS US$0.008 The company reported a decent first half result with improved earnings and profit margins, although revenues were weaker. First half 2021 results: Revenue: US$11.9m (down 16% from 1H 2020). Net income: US$4.00m (up US$7.00m from 1H 2020). Profit margin: 34% (up from net loss in 1H 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. 